Clinical commentary on evidence, oncology decisions, clinical knowledge, and where technology belongs.https://kesis.ca/en-CAhttps://kesis.ca/insights/the-claim-stops-where-the-evidence-stops/https://kesis.ca/insights/the-claim-stops-where-the-evidence-stops/A 9,691-patient trial shows why better documentation, better decisions, and better outcomes require separate evidence.Mon, 27 Jul 2026 00:00:00 GMTDecision SupportDr. Henry Conterhttps://kesis.ca/insights/i-found-out-about-build-week-on-friday-night/https://kesis.ca/insights/i-found-out-about-build-week-on-friday-night/I found OpenAI Build Week on Friday night, built Ariad by Tuesday, and learned why fast clinical products still need reliable medical knowledge.Wed, 22 Jul 2026 00:00:00 GMTIndustry & StrategyDr. Henry Conterhttps://kesis.ca/insights/the-treatment-he-could-not-get-still-belonged-in-the-conversation/https://kesis.ca/insights/the-treatment-he-could-not-get-still-belonged-in-the-conversation/An Ontario oncologist discussed a treatment the system could not yet provide. That conversation matters for patients, clinical records, and funding decisions.Tue, 14 Jul 2026 00:00:00 GMTClinical CommentaryDr. Henry Conterhttps://kesis.ca/insights/the-hardest-decision-in-oncology-is-the-one-you-never-get-to-check/https://kesis.ca/insights/the-hardest-decision-in-oncology-is-the-one-you-never-get-to-check/Why the survival benefit number from an adjuvant trial is never the number a patient is asking for — and where decision support can close that gap.Tue, 16 Jun 2026 00:00:00 GMTClinical CommentaryDr. Henry Conterhttps://kesis.ca/insights/canada-is-building-the-foundation-the-value-is-one-layer-up/https://kesis.ca/insights/canada-is-building-the-foundation-the-value-is-one-layer-up/Canada is building sovereign AI infrastructure for health. The durable value will be made in the layer that turns it into better decisions at the bedside.Tue, 09 Jun 2026 00:00:00 GMTIndustry & StrategyDr. Henry Conterhttps://kesis.ca/insights/the-doctors-who-use-ai-were-never-worried-about-it/https://kesis.ca/insights/the-doctors-who-use-ai-were-never-worried-about-it/AI researchers are walking back doomsday predictions. In oncology the reversal is unsurprising — these tools help with what clinicians never had time to finish.Tue, 02 Jun 2026 00:00:00 GMTIndustry & StrategyDr. Henry Conterhttps://kesis.ca/insights/we-turn-your-survival-curves-into-yes-or-no/https://kesis.ca/insights/we-turn-your-survival-curves-into-yes-or-no/Pharma invests years in continuous trial data. By the time it reaches clinic, most of that precision is gone. Here's where the value actually goes.Tue, 26 May 2026 00:00:00 GMTClinical CommentaryDr. Henry Conterhttps://kesis.ca/insights/what-oncologists-actually-want-from-clinical-decision-support/https://kesis.ca/insights/what-oncologists-actually-want-from-clinical-decision-support/Most CDS tools assume doctors need help remembering guidelines. That's not where oncologists get stuck. Here's what the harder conversations actually look like.Thu, 21 May 2026 00:00:00 GMTDecision SupportDr. Henry Conter